Journal Article

Multiparametric analysis of etoposide exposed mesenchymal stem cells and Fanconi anemia cells: implications in development of secondary myeloid malignancy

Ünal, Şule, Alpdündar-Bulut, Esin, Özdemir, Cansu, Uçkan-Çetinkaya, Duygu, Muratoğlu, Bihter, Özel, Buse Nurten, Tonyalı, Gülsena

2023

Overview

Secondary acute myeloid leukemia (sAML) may develop following a prior therapy or may evolve from an antecedent hematological disorder such as Fanconi Anemia (FA). Pathophysiology of leukemic evolution is not clear. Etoposide (Eto) is a chemotherapeutic agent implicated in development of sAML. FA is an inherited bone marrow (BM) failure disease characterized by genomic instability and xenobiotic susceptibility. Here, we hypothesized that alterations in the BM niche may play a critical/driver role in development of sAML in both conditions. Expression of selected genes involved in xenobiotic metabolism, DNA double-strand break response, endoplasmic reticulum (ER) stress, heat shock response and cell cycle regulation were determined in BM mesenchymal stem cells (MSCs) of healthy controls and FA patients at steady state and upon exposure to Eto at different concentrations and in recurrent doses. Expression of CYPA1 , p53, CCNB1, Dicer1, CXCL12, FLT3L and TGF-Beta genes were significantly downregulated in FA-MSCs compared with healthy controls. Eto exposure induced significant alterations in healthy BM-MSCs with increased expression of CYP1A1, GAD34, ATF4, NUPR1, CXCL12, KLF4, CCNB1 and nuclear localization of Dicer1 . Interestingly, FA-MSCs did not show significant alterations in these genes upon Eto exposure. As opposed to healthy MSCs DICER1 gene expression and intracellular localization was not altered on FA BM-MSCs after Eto treatment. These results showed that Eto is a highly potent molecule and has pleiotropic effects on BM-MSCs, FA cells show altered expression profile compared to healthy controls and Eto exposure on FA cells shows differential profile than healthy controls. Graphical abstract

• Publisher: Springer International Publishing,Springer Nature B.V
• Subject: Acute myeloid leukemia / Anemia / Antibodies / Bone marrow / Cell culture / Cell cycle / Cell growth / Cell Proliferation / Chemotherapy / CXCL12 protein / Cytochrome P450 / DEAD-box RNA Helicases - metabolism / DNA damage / Endoplasmic reticulum / Etoposide / Etoposide - metabolism / Etoposide - pharmacology / Fanconi Anemia - genetics / Fanconi Anemia - metabolism / Fanconi Anemia - pathology / Fanconi syndrome / FLT3L protein / Gene expression / Genomic instability / Heat shock / Hematological diseases / Hematology / Humans / Internal Medicine / KLF4 protein / Leukemia / Leukemia, Myeloid, Acute - genetics / Leukemia, Myeloid, Acute - metabolism / Leukemia, Myeloid, Acute - pathology / Localization / Malignancy / Medicine / Medicine & Public Health / Mesenchymal stem cells / Mesenchymal Stem Cells - metabolism / Oncology / p53 Protein / Pathogenesis / Proteins / Ribonuclease III - metabolism / Senescence / Stem cells / Xenobiotics - metabolism